Skip to content
Screener

Lipocine LPCN Q2 2026 earnings

Reported August 4, 2026 · Before market open

Revenue$190.1KMiss by $22.9K
EPS-$0.32Beat by $0.08
Revenue estimate$213.0K
EPS estimate-$0.40

Next report

Nov 5, 2026 (in a month)
Revenue estimate$159.5K
EPS estimate-$0.39

FAQ

When did Lipocine report Q2 2026 earnings?
Lipocine (LPCN) reported Q2 2026 earnings on August 4, 2026 before market open.
What were Lipocine's Q2 2026 revenue and EPS?
Lipocine reported revenue of $190.1K and eps of $-0.32 for Q2 2026.
Did Lipocine beat estimates in Q2 2026?
Revenue missed the consensus estimate of $213.0K by $22.9K. EPS beat the consensus estimate of $-0.40 by $0.08.
How did Lipocine's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 69.5% from $622.8K a year earlier and eps grew 22.0% from $-0.41.
Where can I find Lipocine's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-035762) and the 10-Q periodic report (0001493152-26-035909) directly on SEC EDGAR. The filing index links above go to sec.gov.